This handout is for hyperosmolar hyperglycemic state (adult). Your care team identified this based on: glucose ≥600 mg/dl (ada 2026 §16; kitabchi 2009).
Other reasons your team may use this plan: ams in elderly diabetic (jbds-ip 2023; scott 2015 uk audit); effective osmolality >300 mosm/kg without ketoacidosis (ada/easd 2024 consensus); known t2dm + dehydration / infection trigger (pasquel 2014; jbds-ip 2023).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| 0.9% sodium chloride | 1 L IV over 1h (no bolus); aim positive balance 3–6 L by 12h, 6–9 L by 24h (JBDS-IP 2023) | IV | continuous | JBDS-IP 06 (2nd ed 2023) — fluids alone often drop glucose by 50–100 mg/dL/h and reduce osmolality before any insulin (Kitabchi 2009) |
Plan: HHS acute — JBDS-IP 06 (2nd ed 2023) fluid-first + delayed low-dose insulin
Call 911 or go to the nearest emergency room right away if you have:
Endo + diabetes education; review precipitant; revise outpatient T2DM regimen per ADA 2026 §9 cardiorenal-first (SGLT2i/GLP-1 RA); medication reconciliation removing precipitating drugs (Beers 2023)
Guideline: 2024 ADA/EASD/JBDS/AACE/DTS Hyperglycemic Crises Consensus + ADA SoC 2026 Ch 16 (Diabetes Care in the Hospital) + JBDS-IP 06 (2nd ed 2022, 2023 update) + KDIGO 2024 CKD (AKI staging) + 2025 AHA/ACC HTN (post-resolution BP)